<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210221050435N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-07</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Level of Metalloproteinase Matrix 8  in Gingival Crevicular Fluid of Mandibular anterior teeth with two types of fixed and removable orthodontic retainers</public_title>
      <acronym></acronym>
      <scientific_title>Level of Metalloproteinase Matrix 8  in Gingival Crevicular Fluid of Mandibular anterior teeth with two types of fixed and removable orthodontic retainers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56547</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: First, using Random allocation software version 1.0 under Windows ,we generate a random sequence using a simple random allocation method. In this table, it is specified from 1 to 22 and each number is assigned to an intervention group (A or B). The first eligible patient is assigned number 1, the second patient is assigned number 2 and so on up to 22 patients. In order to blind the random allocation of clients by a third person who is unaware of the interventions, they are placed in intervention groups (A or B) by this table, Blinding description: In this study, the Patients and the researcher (who is responsible for sampling of Patients) are aware of the type of retainer in the Mandible. But the person in charge of data collection, the statistician consult who is in charge of data analysis, and the person in charge of the laboratory who will eventually analyze the samples are blinded because the information and samples of patients in all the mentioned steps will be identified only by random numbers.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Mandibular Retainer at the end of Orthodontic treatment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After setting the appointment, for each patient in a session, the ESSIX retainer will be  placed in the upper jaw, and according to the group in which they are placed, the banded retainer(Retainer wire Hilgers Bond-A-Braid :Stainless steel, 8-strand, dead soft )  will be placed in the lower jaw.At the time of Debonding, the patient is molded and a cast is prepared for him. To make the retainer, after debonding, the patient is molded using alginate.In the retainer bonding session, first the lingual surface of the mandibular incisor teeth is rinsed with water and gently dried with air . Two pieces of dental floss pass through the contact between the lateral and canine on both sides and the retainer is placed in place. Flossing passes over the retainer and the retainer adapts to the lingual surface of the teeth by applying some force.The lingual surface of these teeth is etched with 37% phosphoric acid and rinsed, and then the retainer is bonded to the lingual surface using TRANSBOND composite.The gingival fluid of these patients will be sampled on the day of debonding, 30 days later and 90 days later. Intervention 2: Intervention group: After setting the appointment, for each patient in a session, the ESSIX retainer is placed in the upper jaw, and according to the group in which they are placed, the ESSIX retainer is placed in the lower jaw. ESSIX retainer (1 mm thick) by Vacuum ،Thermoforming Machine is also made on the cast prepared by the patient after debanding.The gingival fluid of these patients will be sampled on the day of debonding, 30 days later and 90 days later.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After unidentifying individuals, it is possible to share all values ​​of the metalloproteinase matrix and the irrigularity index and overjet and overbite of patients in both treatment groups.

When:
Start the access period 6 months after publishing the results

To whom:
Researchers working in academic and scientific institutions and valid scientific research journals

Conditions:
In order to use the documents of this study for other studies and researches to apply the results

Where to obtain:
Responsible person in this field: Shiva Abdollahi , email address:sh.abdollahi.dds@gmail.com

How to obtain:
The applicant can send his request to the above-mentioned email address with his introduction and the reason for the request and receive the information as soon as possible (finally within 7-10 days).

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein agha Aghili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental school, The beginning of Dahe Fajr Boulevard, Imam Khomeini St, Yazd</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8914881167</zip>
        <telephone>+98 35 3625 5881</telephone>
        <email>hosseinaghily@gmail.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hossein agha Aghili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental school, The beginning of Dahe Fajr Boulevard, Imam Khomeini St, Yazd</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8914881167</zip>
        <telephone>+98 35 3625 5881</telephone>
        <email>hosseinaghily@gmail.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients have been treated with the 022 System and their treatment has been completed with satisfactory correction of malocclusion and appropriate dental alingment.
The Patient's condition is favorable in terms of general health.
Absence of Craniofacial Syndromes and Facial Clefts
Absence of severe and uncontrolled Caries
The Patient should have good oral hygiene and be Periodontally normal.
The Patient should have all the anterior Mandibular teeth and the teeth should be of normal shape and size.</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Lack of Patient cooperation to refer
Observe poor Periodontal status during the study
Break and  not using the retainer
Specific conditions of COVID 19 infection that prevent the Patient from visiting.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After setting the appointment, for each patient in a session, the ESSIX retainer will be  placed in the upper jaw, and according to the group in which they are placed, the banded retainer(Retainer wire Hilgers Bond-A-Braid :Stainless steel, 8-strand, dead soft )  will be placed in the lower jaw.At the time of Debonding, the patient is molded and a cast is prepared for him. To make the retainer, after debonding, the patient is molded using alginate.In the retainer bonding session, first the lingual surface of the mandibular incisor teeth is rinsed with water and gently dried with air . Two pieces of dental floss pass through the contact between the lateral and canine on both sides and the retainer is placed in place. Flossing passes over the retainer and the retainer adapts to the lingual surface of the teeth by applying some force.The lingual surface of these teeth is etched with 37% phosphoric acid and rinsed, and then the retainer is bonded to the lingual surface using TRANSBOND composite.The gingival fluid of these patients will be sampled on the day of debonding, 30 days later and 90 days later.</i_keyword>
      <i_keyword>Intervention group: After setting the appointment, for each patient in a session, the ESSIX retainer is placed in the upper jaw, and according to the group in which they are placed, the ESSIX retainer is placed in the lower jaw. ESSIX retainer (1 mm thick) by Vacuum ،Thermoforming Machine is also made on the cast prepared by the patient after debanding.The gingival fluid of these patients will be sampled on the day of debonding, 30 days later and 90 days later.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Level of Matrix Metalloproteinase 8 after Orthodontic debonding. Timepoint: Immediately after debonding, 30 days after debonding, 90 days after debonding. Method of measurement: Sampling of the gingival crevice fluid will be done and then the amount of  Matrix Metalloproteinase 8 enzyme will be determined with the kit related to the  this enzyme .</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Little irregularity index. Timepoint: Day of debonding, 30 days after debonding, 90 days after debonding. Method of measurement: Evaluation from cast taken from the patient on the days of measurement.</sec_outcome>
      <sec_outcome>Overjet. Timepoint: Day of debonding, 30 days after debonding, 90 days after debonding. Method of measurement: Examination in the patient's mouth on the days of measurement.</sec_outcome>
      <sec_outcome>Overbite. Timepoint: Day of debonding, 30 days after debonding, 90 days after debonding. Method of measurement: Examination in the patient's mouth on the days of measurement.</sec_outcome>
      <sec_outcome>Bleeding after gingival probing. Timepoint: Day of debonding, 30 days after debonding, 90 days after debonding. Method of measurement: Examination in the patient's mouth on the days of measurement.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-01</approval_date>
        <contact_name>Ethic committee of Yazd Shahid sadoughi University of medical science</contact_name>
        <contact_address>Dahe Fajr Boulevard.Imam Reza Street.Shahid Sadoughi University of medical science.Yazd Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
